Shanna Bablonis, Ph.D.

Cannabis and Opioid Interactions: Human Laboratory Studies and Clinical Implications

May 14, 2026 1:00PM MDT

Shanna Babalonis, PhD is an associate professor in the University of Kentucky (UK) College of Medicine Department of Behavioral Science and Center on Drug and Alcohol Research. Her NIH-funded research focuses on clinical trials and human laboratory assessments of the abuse potential, risks, and therapeutic effects of cannabis and opioids to determine how cannabis impacts individuals with opioid use disorder. She serves as the Director of the UK Cannabis Center and is leading a clinical trial to determine the impact of daily oral cannabis doses in patients with cancer.  Dr. Babalonis has co-authored a report on cannabidiol for the World Health Organization, serves as the scientist representative on the Council for Governmental Relations Hemp and Cannabis Group and serves on the program and membership committees for the International Cannabinoid Research Society. She is also a consulting editor for two scientific journals: Cannabis and Medical Cannabis and Cannabinoids. 

Click Here To Register

Previous Webinars

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »

Carolyn Baglole, PhD,

December, 11, 2025 1:00 PM MST

Multi-omics dissection of the molecular and pharmacological effects of inhaled cannabis

Professor Carolyn Baglole earned her Bachelor of Science and Master of Science degrees from the University of Prince Edward Island, followed by a PhD in Physiology and Pharmacology from the University of Calgary. Dr. Baglole then completed postdoctoral training at […]

Read More »

Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is […]

Read More »

Inga Zasada, Ph.D.

Wednesday, February 18 at 11:00 AM MST

Dr. Inga Zasada brings over 25 years of expertise in nematology, specializing in the biology and management of plant-parasitic nematodes affecting high-value crops such as hemp. With deep knowledge spanning both chemical and nonchemical control strategies, she provides comprehensive solutions for complex nematode challenges. As owner of NemaSolutions LLC, […]

Read More »

Dan Ovadya, CEO

New Methods for Induction of Male Flowers and Scalable Feminized Seed Production in Cannabis Sativa

Dan Ovadya is the Co-founder and CEO of FloraGen LLC, an AgTech company based in Davis, California. Dan has
over 30 years of experience in crop optimization, precision horticulture and seed production systems in controlled
environments. His career in Ag-Biotech centered on developing […]

Read More »